Back to Search Start Over

Orexin receptors in GtoPdb v.2021.3

Authors :
Jim J. Hagan
John J. Renger
Thomas S. Kilduff
Paul J. Coleman
Jerome M. Siegel
Jyrki P. Kukkonen
Christopher J. Winrow
Luis de Lecea
Daniel Hoyer
Roderick A. Porter
Anthony L. Gotter
Gregor J Sutcliffe
Neil Upton
Source :
IUPHAR BPS Guide Pharm CITE
Publication Year :
2021
Publisher :
Edinburgh University Library, 2021.

Abstract

Orexin receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Orexin receptors [42]) are activated by the endogenous polypeptides orexin-A and orexin-B (also known as hypocretin-1 and -2; 33 and 28 aa) derived from a common precursor, preproorexin or orexin precursor, by proteolytic cleavage and some typical peptide modifications [109]. Currently the only orexin receptor ligands in clinical use are suvorexant and lemborexant, which are used as hypnotics. Orexin receptor crystal structures have been solved [134, 133, 54, 117, 46].

Details

ISSN :
26331020
Volume :
2021
Database :
OpenAIRE
Journal :
IUPHAR/BPS Guide to Pharmacology CITE
Accession number :
edsair.doi.dedup.....c1196f26965e8dd135a136421a8771cb
Full Text :
https://doi.org/10.2218/gtopdb/f51/2021.3